本レポートは、力強い成長を経験しているオーファンドラッグ市場に焦点を当てています。今後10年以上にわたって私たちの生活を形作り変化させるオーファンドラッグ市場へのガイドを提供します。
目次
Table of Contents
1. Executive Summary
2. Orphan Drugs Market Characteristics
3. Orphan Drugs Market Trends And Strategies
4. Orphan Drugs Market - Macro Economic Scenario
4.1 COVID - 19 Impact On Orphan Drugs Market
4.2 Ukraine - Russia War Impact On Orphan Drugs Market
4.3 Impact Of High Inflation On Orphan Drugs Market
5. Orphan Drugs Market Size And Growth
5.1. Global Orphan Drugs Historic Market, 2017 - 2022, $ Billion
5.1.1. Drivers Of The Market
5.1.2. Restraints On The Market
5.2. Global Orphan Drugs Forecast Market, 2022 - 2027F, 2032F, $ Billion
5.2.1. Drivers Of The Market
5.2.2. Restraints On the Market
6. Orphan Drugs Market Segmentation
6.1. Global Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Oncology
Blood
Central Nervous System
Endocrine
Cardiovascular
Respiratory
Immunomodulatory
6.2. Global Orphan Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Hospital Pharmacy
Retail Pharmacy
Online Sales
6.3. Global Orphan Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Biological
Non - Biological
6.4. Global Orphan Drugs Market, Segmentation By Diesease Type, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Oncology
Hematology
Neurology
Cardiovascular
Other Diesease Types
7. Orphan Drugs Market Regional And Country Analysis
7.1. Global Orphan Drugs Market, Split By Region, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
7.2. Global Orphan Drugs Market, Split By Country, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
8. Asia - Pacific Orphan Drugs Market
8.1. Asia - Pacific Orphan Drugs Market Overview
Region Information, Impact Of COVID - 19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia - Pacific Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
9. China Orphan Drugs Market
9.1. China Orphan Drugs Market Overview
9.2. China Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F,$ Billion
10. India Orphan Drugs Market
10.1. India Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
11. Japan Orphan Drugs Market
11.1. Japan Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
12. Australia Orphan Drugs Market
12.1. Australia Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
13. Indonesia Orphan Drugs Market
13.1. Indonesia Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
14. South Korea Orphan Drugs Market
14.1. South Korea Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
15. Western Europe Orphan Drugs Market
15.1. Western Europe Orphan Drugs Market Overview
15.2. Western Europe Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
16. UK Orphan Drugs Market
16.1. UK Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
17. Germany Orphan Drugs Market
17.1. Germany Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
18. France Orphan Drugs Market
18.1. France Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
19. Eastern Europe Orphan Drugs Market
19.1. Eastern Europe Orphan Drugs Market Overview
19.2. Eastern Europe Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
20. Russia Orphan Drugs Market
20.1. Russia Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
21. North America Orphan Drugs Market
21.1. North America Orphan Drugs Market Overview
21.2. North America Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
22. USA Orphan Drugs Market
22.1. USA Orphan Drugs Market Overview
22.2. USA Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
23. South America Orphan Drugs Market
23.1. South America Orphan Drugs Market Overview
23.2. South America Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
24. Brazil Orphan Drugs Market
24.1. Brazil Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
25. Middle East Orphan Drugs Market
25.1. Middle East Orphan Drugs Market Overview
25.2. Middle East Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
26. Africa Orphan Drugs Market
26.1. Africa Orphan Drugs Market Overview
26.2. Africa Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
27. Orphan Drugs Market Competitive Landscape And Company Profiles
27.1. Orphan Drugs Market Competitive Landscape
27.2. Orphan Drugs Market Company Profiles
27.2.1. Bristol - Myers Squibb Company
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Celgene Corporation
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. F. Hoffmann - La Roche Ltd
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Amgen
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Biogen
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance
28. Orphan Drugs Pipeline Analysis
29. Key Mergers And Acquisitions In The Orphan Drugs Market
30. Orphan Drugs Market Future Outlook and Potential Analysis
31. Appendix
31.1. Abbreviations
31.2. Currencies
31.3. Historic And Forecast Inflation Rates
31.4. Research Inquiries
31.5. The Business Research Company
31.6. Copyright And Disclaimer
List of Tables
Table 1: Global Historic Market Growth, 2017 - 2022, $ Billion
Table 2: Global Forecast Market Growth, 2022 - 2027F, 2032F, $ Billion
Table 3: Global Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 4: Global Orphan Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 5: Global Orphan Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 6: Global Orphan Drugs Market, Segmentation By Diesease Type, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 7: Global Orphan Drugs Market, Split By Region, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 8: Global Orphan Drugs Market, Split By Country, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 9: Asia - Pacific, Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 10: China, Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 11: India, Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 12: Japan, Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 13: Australia, Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 14: Indonesia, Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 15: South Korea, Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 16: Western Europe, Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 17: UK, Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 18: Germany, Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 19: France, Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 20: Eastern Europe, Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 21: Russia, Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 22: North America, Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 23: USA, Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 24: South America, Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 25: Brazil, Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 26: Middle East, Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 27: Africa, Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Table 28: Bristol - Myers Squibb Company Financial Performance
Table 29: Celgene Corporation Financial Performance
Table 30: F. Hoffmann - La Roche Ltd Financial Performance
Table 31: Amgen Financial Performance
Table 32: Biogen Financial Performance
List of Figures
Figure 1: Global Historic Market Growth, 2017 - 2022, $ Billion
Figure 2: Global Forecast Market Growth, 2022 - 2027F, 2032F, $ Billion
Figure 3: Global Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 4: Global Orphan Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 5: Global Orphan Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 6: Global Orphan Drugs Market, Segmentation By Diesease Type, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 7: Global Orphan Drugs Market, Split By Region, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 8: Global Orphan Drugs Market, Split By Country, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 9: Asia - Pacific, Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 10: China, Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 11: India, Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 12: Japan, Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 13: Australia, Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 14: Indonesia, Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 15: South Korea, Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 16: Western Europe, Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 17: UK, Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 18: Germany, Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 19: France, Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 20: Eastern Europe, Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 21: Russia, Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 22: North America, Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 23: USA, Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 24: South America, Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 25: Brazil, Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 26: Middle East, Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 27: Africa, Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2017 - 2022, 2022 - 2027F, 2032F, $ Billion
Figure 28: Bristol - Myers Squibb Company Financial Performance
Figure 29: Celgene Corporation Financial Performance
Figure 30: F. Hoffmann - La Roche Ltd Financial Performance
Figure 31: Amgen Financial Performance
Figure 32: Biogen Financial Performance
